Found: 18
Select item for more details and to access through your institution.
Analysis of Risk Factors for High-dose Cisplatin-induced Renal Impairment in Head and Neck Cancer Patients.
- Published in:
- In Vivo, 2022, v. 36, n. 5, p. 2465, doi. 10.21873/invivo.12982
- By:
- Publication type:
- Article
Severe Skin Disorders Due to Sorafenib Use After Nivolumab Treatment in Renal Cell Carcinoma Patients.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Translocation of tyrosine-phosphorylated TCRζ chain to glycolipid-enriched membrane domains upon T cell activation.
- Published in:
- International Immunology, 1999, v. 11, n. 9, p. 1395, doi. 10.1093/intimm/11.9.1395
- By:
- Publication type:
- Article
Mitigation of Global Cooling by Stratospheric Chemistry Feedbacks in a Simulation of the Last Glacial Maximum.
- Published in:
- Journal of Geophysical Research. Atmospheres, 2018, v. 123, n. 17, p. 9378, doi. 10.1029/2017JD028017
- By:
- Publication type:
- Article
Impact of interactive chemistry of stratospheric ozone on Southern Hemisphere paleoclimate simulation.
- Published in:
- Journal of Geophysical Research. Atmospheres, 2017, v. 122, n. 2, p. 878, doi. 10.1002/2016JD025508
- By:
- Publication type:
- Article
Isolation and identification of oryzamutaic acids A and D from an Oryza sativa spontaneous mutant with yellow endospem.
- Published in:
- Breeding Science, 2011, v. 61, n. 1, p. 93, doi. 10.1270/jsbbs.61.93
- By:
- Publication type:
- Article
Differences in water diffusion and lactate production in two different types of postinfectious encephalopathy.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Population Pharmacokinetics and Therapeutic Efficacy of Febuxostat in Patients with Severe Renal Impairment.
- Published in:
- Pharmacology, 2015, v. 96, n. 1/2, p. 90, doi. 10.1159/000434633
- By:
- Publication type:
- Article
Do Structural Changes of T Cell Receptor Complex Occur in Tumor-bearing State?
- Published in:
- Cancer Science, 1995, v. 86, n. 4, p. 383, doi. 10.1111/j.1349-7006.1995.tb03068.x
- By:
- Publication type:
- Article
Pre-existing autoimmune disease as a risk factor for immune-related adverse events in cancer patients receiving immune checkpoint inhibitors.
- Published in:
- PLoS ONE, 2024, v. 19, n. 7, p. 1, doi. 10.1371/journal.pone.0306995
- By:
- Publication type:
- Article
Oxidized cholesterol modulates age-related change in lipid metabolism in rats.
- Published in:
- Lipids, 1995, v. 30, n. 5, p. 405, doi. 10.1007/BF02536298
- By:
- Publication type:
- Article
Relationships of Proton Pump Inhibitor‐Induced Renal Injury with CYP2C19 Polymorphism: A Retrospective Cohort Study.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 5, p. 1141, doi. 10.1002/cpt.3183
- By:
- Publication type:
- Article
Oral mucositis associated with anti-EGFR therapy in colorectal cancer: single institutional retrospective cohort study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Exploratory analysis of target concentration of lenvatinib in the treatment of hepatocellular carcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 2, p. 281, doi. 10.1007/s00280-021-04286-2
- By:
- Publication type:
- Article
Sorafenib exposure and its correlation with response and safety in advanced hepatocellular carcinoma: results from an observational retrospective study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Pharmacokinetic interaction between sorafenib and prednisolone in a patient with hepatocellular carcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 1, p. 269, doi. 10.1007/s00280-013-2187-9
- By:
- Publication type:
- Article
Granisetron plus aprepitant versus granisetron in preventing nausea and vomiting during CHOP or R-CHOP regimen in malignant lymphoma: a retrospective study.
- Published in:
- Journal of Pharmaceutical Health Care & Sciences, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1186/s40780-019-0153-3
- By:
- Publication type:
- Article
Pharmacokinetic/Pharmacodynamic Analysis of a Hemodialyzed Patient Treated with 25 mg of Sunitinib.
- Published in:
- Case Reports in Oncology, 2012, v. 5, n. 3, p. 627, doi. 10.1159/000345694
- By:
- Publication type:
- Article